基于臀大肌 MRI 亚区域影像组学预测高级别浆液性卵巢癌复发
多中心回顾性队列纳入 531 例高级别浆液性卵巢癌患者,基于 T2WI 自动分割臀大肌并构建亚区域影像组学模型。亚区域模型预测复发 AUC 为 0.717–0.774,联合临床因素后 AUC 提升至 0.733–0.817,NRI 与 IDI 显示显著净临床获益。
要点
- 臀大肌亚区域影像组学较常规影像组学及深度学习模型更能预测 HGSOC 复发
- 联合新辅助化疗和 PARP 抑制剂治疗的临床模型可进一步提升复发预测效能
- T2WI 自动分割臀大肌的 DSC 为 0.726–0.903,分割稳定性可接受
核心结论
- 基于 T2WI 的臀大肌亚区域影像组学模型可有效预测高级别浆液性卵巢癌患者复发。
- 联合亚区域影像组学特征与临床因素的综合模型总体提高预测准确性。
研究设计与样本
- 多中心回顾性队列研究,纳入 531 例高级别浆液性卵巢癌患者。
- 采用 U-Net 架构在 T2WI 上自动分割臀大肌感兴趣区。
- 通过高斯混合模型分离肌肉与脂肪特征构建亚区域影像组学模型。
关键影像表现/征象
- 臀大肌 T2WI 自动分割 Dice 相似系数为 0.726–0.903。
- 亚区域影像组学通过高斯混合模型分离臀大肌内肌肉与脂肪特征。
诊断标准与关键数值
- 亚区域影像组学模型 AUC:训练集 0.774,内部验证 0.774,外部测试 A 0.717,外部测试 B 0.704,外部测试 C 0.717。
- 综合模型 AUC:训练集 0.817,内部验证 0.814,外部测试 A 0.746,外部测试 B 0.799,外部测试 C 0.733。
- 新辅助化疗和 PARP 抑制剂治疗为高级别浆液性卵巢癌复发的独立预测因素(P < 0.05)。
- NRI 与 IDI 分析证实亚区域影像组学模型和综合模型具有显著净临床获益。
临床应用与阅片要点
- 阅片时可关注臀大肌 T2WI 信号分布,自动分割与亚区域特征提取有助复发风险评估。
- T2WI 自动分割臀大肌 DSC 为 0.726–0.903,分割用于临床报告前需注意边界误差。
局限性
- 研究为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the predictive value of MRI sub-regional radiomics of the gluteus maximus for recurrence in high-grade serous ovarian cancer (HGSOC) and compare its performance with conventional radiomics and deep learning (DL) models.
METHODS: A multi-center retrospective cohort of 531 patients with HGSOC was analyzed. A U-Net architecture was utilized to automatically segment the region of interest (ROI) of gluteus maximus on T2-weighted imaging (T2WI). Radiomics and DL models were developed using features extracted from the whole ROI. Additionally, sub-regional radiomics models were developed by segregating muscle and fat features through Gaussian Mixture Model (GMM). The optimal predictive model was then integrated with independent clinical predictors to form a combined model. Automatic segmentation accuracy was evaluated using the Dice Similarity Coefficient (DSC). Model performance and clinical utility were assessed using the area under the curve (AUC), net reclassification index (NRI), and integrated discrimination index (IDI).
RESULTS: Neoadjuvant chemotherapy (NACT) and poly ADP-ribose polymerase (PARP) inhibitor treatment were identified as independent predictors of HGSOC recurrence (P < 0.05). The U-Net segmentation achieved DSC ranging from 0.726 to 0.903 across cohorts. The sub-regional radiomics model demonstrated superior performance compared to clinical, conventional radiomics, and DL models, achieving AUCs of 0.774 (training), 0.774 (internal validation), 0.717 (external test A), 0.704 (external test B), and 0.717 (external test C). Integrating sub-regional radiomics with clinical factors yielded a combined model with improved AUCs of 0.817, 0.814, 0.746, 0.799, and 0.733, respectively. NRI and IDI analyses confirmed significant net clinical benefits for both the sub-regional radiomics and combined models.
CONCLUSION: The T2WI-based sub-regional radiomics model of the gluteus maximus effectively predicts recurrence in HGSOC patients. The combined model, which integrates sub-regional radiomics features with clinical factors, generally improves predictive accuracy and provides a promising decision-support tool for post-treatment assessment of recurrence risk.
引用
- Bi, Wang, Tan, et al. A clinical-radiomics model based on MRI sub-regions of gluteus maximus for recurrence prediction in high-grade serous ovarian cancer. Abdom Radiol (NY). 2026. PMID: 42570087. doi:10.1007/s00261-026-05716-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。